These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment. Huang Y, Sharma VK, Robinson T, Lindley RI, Chen X, Kim JS, Lavados P, Olavarría V, Arima H, Fuentes S, Nguyen HT, Lee TH, Parsons MW, Levi C, Demchuk AM, Bath PM, Broderick JP, Donnan GA, Martins S, Pontes-Neto OM, Silva F, Pandian J, Ricci S, Stapf C, Woodward M, Wang J, Chalmers J, Anderson CS, ENCHANTED investigators. Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995 [Abstract] [Full Text] [Related]
4. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China). Fan Y, Liao X, Pan Y, Dong K, Wang Y, Wang Y, Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China) InvestigatorsDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China; Department of Neurology, Baotou Central Hospital, Baotou, Inner Mongolia, China.. J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863 [Abstract] [Full Text] [Related]
9. Low-dose rt-PA may not decrease the incidence of symptomatic intracranial haemorrhage in patients with high risk of symptomatic intracranial haemorrhage. Liu M, Pan Y, Zhou L, Wang Y. Neurol Res; 2019 May; 41(5):473-479. PubMed ID: 30822264 [Abstract] [Full Text] [Related]
10. Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator. Huang YH, Zhuo ST, Chen YF, Li MM, Lin YY, Yang ML, Chen ZJ, Cai RW. Chin Med J (Engl); 2013 May; 126(24):4685-90. PubMed ID: 24342312 [Abstract] [Full Text] [Related]
17. Association of 24 h Blood Pressure on Functional Outcome in Patients with Acute Ischemic Stroke Post Intravenous Thrombolysis. Reddy S, Paramasivan NK, Sreedharan SE, Sukumaran S, Vinoda Thulaseedharan J, Sylaja PN. Cerebrovasc Dis; 2023 Dec; 52(2):177-183. PubMed ID: 36423595 [Abstract] [Full Text] [Related]
18. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry. Deguchi I, Dembo T, Yoshimura S, Sakai N, Okada Y, Kitagawa K, Kimura K, Hyogo T, Yamagami H, Egashira Y, Tanahashi N. J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994 [Abstract] [Full Text] [Related]